Departments of Medicine, The Center for Translational Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
Am J Physiol Endocrinol Metab. 2024 Dec 1;327(6):E711-E722. doi: 10.1152/ajpendo.00294.2024. Epub 2024 Oct 23.
The study of the senile osteoporosis in men still lags significantly behind that in women. The changes of protein molecule levels and their relationships with bone loss remain poorly understood. In the present study, we used C57BL/6J male mice at ages from 3 to 24 mo to delineate the mechanisms of aging effects on bone loss. We used the microcomputed tomography, mechanical testing, histomorphometry assays, and detection of serum levels of undercarboxylated osteocalcin (ucOcn) and carboxylated osteocalcin (cOcn) to assess bone mass changes and their relationships with the ratios of ucOcn-to-cOcn in mice from different age groups. The results showed that mouse trabecular bone mass reduced gradually with age, whereas cortical bone loss and mechanical property changes mostly occurred in advanced age. Our findings further demonstrated that the increase in osteoclast activity and the decrease in osteoblast function were significantly corelated with blood levels of ucOcn and cOcn, respectively. The dynamic metabolic changes of ucOcn to cOcn ratio were correlated with age-dependent bone loss in mice. In summary, metabolic shifts in the ratio of ucOcn to cOcn toward bone resorption from young adult to elderly mice contribute to the pathogenesis of age-related bone loss. Simultaneously monitoring blood ratios of ucOcn-to-cOcn may be useful to predict the status of bone mass in vivo. To our knowledge, our finding in this study shows for the first time that metabolic shifts in ratio of ucOcn to cOcn toward bone resorption are markedly correlated with age-dependent bone loss in male mice. These findings for the effects of aging on bone loss will assist in studying the pathogenesis of human type II osteoporosis.
男性老年性骨质疏松症的研究仍然明显落后于女性。蛋白质分子水平的变化及其与骨丢失的关系仍知之甚少。在本研究中,我们使用 3 至 24 月龄的 C57BL/6J 雄性小鼠来描绘衰老对骨丢失的影响机制。我们使用 microCT、力学测试、组织形态计量学检测以及血清下羧化骨钙素 (ucOcn) 和羧化骨钙素 (cOcn) 水平的检测来评估不同年龄组小鼠的骨量变化及其与 ucOcn/cOcn 比值的关系。结果表明,小鼠小梁骨量随年龄逐渐减少,而皮质骨丢失和力学性能变化主要发生在老年期。我们的研究结果进一步表明,破骨细胞活性的增加和成骨细胞功能的降低分别与血液中 ucOcn 和 cOcn 的水平显著相关。ucOcn/cOcn 比值的动态代谢变化与小鼠的年龄相关性骨丢失相关。总之,ucOcn/cOcn 比值从年轻成年到老年小鼠向骨吸收的代谢变化有助于年龄相关性骨丢失的发病机制。同时监测血液中 ucOcn/cOcn 的比值可能有助于预测体内骨量的状态。据我们所知,本研究的发现首次表明,ucOcn/cOcn 比值向骨吸收的代谢变化与雄性小鼠的年龄相关性骨丢失明显相关。这些关于衰老对骨丢失影响的发现将有助于研究人类 II 型骨质疏松症的发病机制。